A Pilot Study of Busulfan, Cyclophosphamide and Etoposide Followed by Autologous Transplantation for Acute Myeloid Leukemia in Remission

European LeukemiaNet classification intermediate risk-1 cohort is associated with poor outcomes in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation

“…Most patients (>95%) received induction chemotherapy followed by one or two cycles of consolidation therapy before transplantation. The patients underwent transplantation using a variety of myeloablative 6, 7, 8, 9 and reduced-intensity 10, 11 regimens. Patients received bone marrow or granulocyte colony-stimulating factor-mobilized blood from HLA-matched donors.…”